Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
6h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
7h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
9h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
17h agoBuffalo Potash Files Annual Information Form and New Technical Report
18h agoIonik Announces 30-Day Extension of Senior Debt Facility
Viatris Inc. logo

Viatris Inc.

About

16.65USD+0.19 +1.15%
Closed • Updated at 20:44 GMT+00:00
Market Cap$19.39B
Volume7.36M
Beta1.41
RSI60.83
Gross Margin38.90%
Health TechnologyPharmaceuticals: Major

Viatris Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 18 2026
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
May 7 2026
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference
May 4 2026
Viatris Announces Chief Financial Officer Transition
May 1 2026
Chlorpheniramine Maleate - Global Market Insights, Competitive Landscape & Industry Forecast to 2033 Featuring Viatris, Alkem Labs, Merck & Co., Johnson & Johnson, Capellon Pharma and More
May 1 2026
Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting

Community Chat

Ask AI

Try asking
6ix6ixAIEvents